GLP-1 Medications After Bariatric Surgery: What Patients Should Know
Dr. Michael Baptista, a Jacksonville bariatric surgeon, explains how GLP-1 medications are being studied for patients who have regained weight after gastric sleeve, bypass, or band surgery, and what a physician-supervised approach looks like.


The Short Answer
Yes, GLP-1 medications can be used after bariatric surgery, and a growing body of research suggests they may help patients who have experienced weight regain following a gastric sleeve, gastric bypass, or gastric band. The decision is not automatic. It depends on why the weight came back, what your anatomy looks like now, and whether medication is the right tool for your situation. That is a conversation to have with Dr. Michael Baptista, not a decision to make from an article.
Why This Question Comes Up
Bariatric surgery remains the most effective long-term treatment for severe obesity. Most patients lose a significant amount of weight in the first year or two and keep most of it off. Over the years, a small number of patients can experience a slow weight regain. That can happen for many reasons: changes in eating patterns, a stretched stomach pouch, hormonal shifts, life circumstances, or medical issues unrelated to the surgery itself.
Until recently, the options for those patients were limited to lifestyle counseling or revisional surgery. The arrival of GLP-1 receptor agonists has added a third path, and patients are asking about it. Many of the people who contact our office with this question did not have their original surgery with us. Some had surgery years ago, some out of state, and some with a surgeon who has since retired. That is one of the reasons I built a physician-supervised medical weight loss program.
What the Research Says
The evidence is still developing, but it is moving in a consistent direction.
A real-world study using the OneFlorida+ research network followed adults who had regained at least 10 percent of their lowest post-surgery weight. Those who started a GLP-1 medication lost significantly more of that regained weight than those who did not, at both six and twelve months, with no increase in adverse events during the study period.
A 2025 systematic review pooled eight retrospective studies covering nearly a thousand patients with weight recurrence after bariatric surgery. Both semaglutide and tirzepatide were associated with meaningful total body weight loss in this group.
A separate 2025 study published in BMC Endocrine Disorders looked at twelve months of GLP-1 therapy in patients with post-surgery weight regain and reported weight loss with an acceptable safety profile.
An editorial in JAMA Surgery in October 2025 summarized where things stand: GLP-1 medications are increasingly being used as an adjunct after bariatric surgery, retrospective studies are encouraging, and prospective evidence is still limited. That last point matters. Most of what we know comes from looking backward at patient records rather than from controlled trials designed to answer this exact question.
In plain language: the early data is promising, and careful physicians are using these medications after surgery, but it is not a settled science, and it should not be treated like one.
Why a Bariatric Surgeon Should Be Part of the Decision
Prescribing a GLP-1 medication to a patient who has had bariatric surgery is different from prescribing it to someone who has not. A few things I consider before prescribing:
Why the weight came back. Regain can have an anatomical cause, such as an enlarged pouch or a widened connection after gastric bypass, or a stretched sleeve. Patients went back eating products that caused the weight regain. Medication does not fix anatomy or bad food choices. In some cases, an evaluation shows that revisional surgery is the more appropriate answer, and in others the anatomy is fine and medication makes sense, since it can aid you with the “cravings.” You cannot know which without an evaluation.
Nutrition and absorption. Most bariatric procedures make you not as hungry. Others will limit how the body absorbs nutrients. Adding a medication that reduces appetite further requires attention to protein intake, vitamin levels, and muscle preservation. This is why I built dietitian support into the program rather than treating it as an afterthought.
Side effects with altered anatomy. GLP-1 medications commonly cause nausea, reflux, or changes in digestion. In a patient with a smaller stomach or rerouted intestine, those effects can present differently and need closer monitoring.
The rest of your health. Blood sugar, blood pressure, sleep apnea, and other conditions that improved after surgery may need to be rechecked and managed alongside any new medication.
What a Physician-Supervised Approach Looks Like
Our Medical Weight Loss Program is a six-month, physician-supervised program. It begins with an evaluation with me, which includes a review of your surgical history, current health, labs, and goals. We will go over the data on the GLP-1 agonist and discuss real expectations regarding how much weight loss is expected. Medication is prescribed when appropriate. From there, patients have monthly follow-up visits, work with a dietitian, and have a dedicated patient care specialist as a point of contact between visits.
The program serves new patients, current patients, and patients who had surgery elsewhere.
Which medication, if any, is right for a given patient is an individual decision made during the evaluation. I do not recommend one medication over another in general terms, because the right choice depends on your history, your health, and how your body responds. You can read about the medications currently approved for weight management on our weight loss medications page.
A Note on Insurance
Our team will assist you in verifying your benefits, however insurance coverage can vary based on your specific plan and it is always subject to change. We encourage patients to contact their insurance provider directly to confirm coverage and benefits.
The Next Step
If you had bariatric surgery, here or anywhere else, and you have noticed weight coming back, the most useful thing you can do is get evaluated by a bariatric surgeon. That evaluation is where the real answer lives, whether it turns out to be medication, revisional surgery, nutrition support, or simply reassurance.
Call our office at (904) 724-2263 or contact us online to schedule a consultation. You can also read more about our Medical Weight Loss Program and our medical weight loss FAQ.
Sources
- Real-World Effectiveness and Safety of GLP-1 Receptor Agonists Among Patients With Weight Recurrence After Bariatric Surgery. OneFlorida+ Data Trust cohort, 2015 to 2024. Published 2026.
- Systematic review and meta-analysis of GLP-1 receptor agonists for weight recurrence after bariatric surgery, 2025 (eight retrospective studies, 964 patients).
- Jensen AB, et al. Efficacy of 12 months therapy with GLP-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery. BMC Endocrine Disorders. 2025;25:93.
- Lauer KV, Harris DA, Funk LM. The GLP-1 Era: What Comes After Bariatric Surgery? JAMA Surgery. 2025;160(10):1066-1067.
This article is for general education and is not a substitute for medical advice. Please see our medical disclaimer.
